Evidence map›Paper›PMID 36580960›Full record

ArticleArquivos de neuro-psiquiatria2022

Botulism in the Brazilian Amazon: a life-threatening disease in a neglected population.

Louise Makarem Oliveira, Daniel Buzaglo Gonçalves, Lucas de Cristo Rojas Cabral, Marília Rosa Abtibol Bernardino, Pablo Vinícius Silveira Feitoza

Open access · goldAbstract read
In one paragraph

Article in Arquivos de neuro-psiquiatria, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Botulism Sequelae: A Systematic Review.Open forum infectious diseases · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Louise Makarem OliveiraUniversidade Federal do Amazonas, Faculdade de Medicina, Manaus AM, Brazil.ORCID 0000-0002-1057-1101
Daniel Buzaglo GonçalvesUniversidade Federal do Amazonas, Faculdade de Medicina, Manaus AM, Brazil.ORCID 0000-0002-3243-970X
Lucas de Cristo Rojas CabralUniversidade Federal do Amazonas, Faculdade de Medicina, Manaus AM, Brazil.ORCID 0000-0002-2943-6137
Marília Rosa Abtibol BernardinoUniversidade Federal do Amazonas, Faculdade de Medicina, Manaus AM, Brazil.ORCID 0000-0003-4093-226X
Pablo Vinícius Silveira FeitozaUniversidade Federal do Amazonas, Faculdade de Medicina, Manaus AM, Brazil.ORCID 0000-0003-2840-451X
Universidade Federal do Amazonas · BRFundação de Medicina Tropical · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBotulism is a rare and potentially fatal neuroparalytic syndrome caused by the gram-positive anaerobe spore-forming bacterium

objectiveTo describe the recent outbreak of botulism cases and its demographic, clinical, and laboratory characteristics.

methodsWe report 4 patients with botulism in the recent outbreak occurred between 2017 and 2019 in the state of Amazon.

resultsOut of four patients with botulism, three contracted it from eating contaminated food and one had wound botulism. We emphasize the excellent clinical outcome of the different disease presentations in our case series.

conclusionThe temporal proximity of these reports may suggest a new rise in the number of cases in the upcoming years. A possible hypothesis is that the rarity of the disease decreased the awareness regarding the primary prevention or even a diagnosis by an untrained physician.

Indexed as

Botulinum ToxinsBotulismClostridium botulinumBrazilDisease OutbreaksHumansBotulinum Toxins

Identifiers

PMID36580960
PMCPMC9800156
OpenAlexW4313332656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.